FDA Inspection 782687 — Claris Lifesciences Inc
The FDA completed an inspection of Claris Lifesciences Inc on May 18, 2012 in North Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 18, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- North Brunswick, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)